-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
According to foreign media reports, Pfizer of the United States and German pharmaceutical company BioNTech submitted to the US Food and Drug Administration (FDA) on the 26th local time to apply for authorization
for children aged 5 to 11 years old to receive a specially upgraded version of the new crown vaccine booster injection.
According to the National Public Radio (NPR) of the United States, this new generation of new crown vaccine booster can fight against the original strain of the new crown and the two subtypes of Omikron BA.
Pfizer and BioNTech also plan to submit applications
to the European Medicines Agency.
It is reported that on August 31, local time, the US Food and Drug Administration has approved the Modener and Pfizer upgraded new crown vaccines
against the Omichron strain.
According to the latest statistics from Johns Hopkins University in the United States, as of 12:00 on the 27th, the cumulative number of confirmed covid-19 cases in the United States exceeded 96.
